LabOmics

LabOmics has been active since 2008 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €169,661 and a net result of €34,189. Equity is growing by about 5.2% per year across the filed financial years. Its solvency ranks better than 77% of 268 sector peers (NACE 72, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).